Thumbnail Image
Item

Lung volume reduction surgery is safe and leads to functional improvement in patients who fail or cannot undergo bronchoscopic lung volume reduction

Magarinos, Jessica
; 
Egelko, Aron
; 
Criner, Gerard J.
; 
Abbas, Abbas
; 
Enofe, Nosayaba
; 
Thomas, JiJi
; 
Carney, Kevin
; 
Friedberg, Joseph
; 
Bakhos, Charles
Citations
Altmetric:
Genre
Journal article
Date
2024-02-12
Advisor
Committee member
Group
Temple University. Hospital
Department
Subject
Bronchoscopy
 Emphysema
 Lung volume reduction
 Outcomes
 Surgery
Permanent link to this record
https://scholarshare.temple.edu/handle/20.500.12613/11806
Collections
Faculty/Researcher Works
Show all metadata
Files
Thumbnail Image
MargarinosEtAl-JournalArticle-2024-02.pdf
Adobe PDF, 1005.08 KB
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1016/j.xjon.2024.02.004
Abstract
Background: Bronchoscopic lung volume reduction (BLVR) has supplanted surgery in the treatment of patients with advanced emphysema, but not all patients qualify for it. Our study aimed to investigate the outcomes of lung volume reduction surgery (LVRS) among patients who either failed BLVR or were not candidates for it. Methods: We conducted a retrospective analysis of patients who underwent LVRS for upper lobe–predominant emphysema at a single tertiary center between March 2018 and December 2022. The main outcomes measures were preoperative and postoperative respiratory parameters, perioperative morbidity, and mortality. Results: A total of 67 LVRS recipients were evaluated, including 10 who had failed prior valve placement. The median patient age was 69 years, and 35 (52%) were male. All procedures were performed thoracoscopically, with 36 patients (53.7%) undergoing bilateral LVRS. The median hospital length of stay was 7 days (interquartile range, 6-11 days). Prolonged air leak (>7 days) occurred in 20 patients. There was one 90-day mortality from a nosocomial pneumonia (non–COVID-related) and no further deaths at 12 months. There were mean improvements of 10.07% in forced expiratory volume in 1 second and 4.74% in diffusing capacity of the lung for carbon monoxide, along with a mean decrease 49.2% in residual volume (P < .001 for all). The modified Medical Research Council dyspnea scale was improved by 1.84 points (P<.001). Conclusions: LVRS can be performed safely in patients who are not candidates for BLVR and those who fail BLVR and leads to significant functional improvement. Long-term follow-up is necessary to ensure the sustainability of LVRS benefits in this patient population.
Description
Citation
Jessica Magarinos, Aron Egelko, Gerard J. Criner, Abbas Abbas, Nosayaba Enofe, JiJi Thomas, Kevin Carney, Joseph Friedberg, Charles Bakhos, Lung volume reduction surgery is safe and leads to functional improvement in patients who fail or cannot undergo bronchoscopic lung volume reduction, JTCVS Open, Volume 18, 2024, Pages 369-375, ISSN 2666-2736, https://doi.org/10.1016/j.xjon.2024.02.004. (https://www.sciencedirect.com/science/article/pii/S2666273624000391)
Citation to related work
Elsevier
Has part
JTCVS Open, Vol. 18
ADA compliance
Embedded videos
License
Attribution-NonCommercial-NoDerivs CC BY-NC-ND
cbn